Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial
Titel:
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial
Auteur:
Swaminath, Anand Wierzbicki, Marcin Parpia, Sameer Wright, James R. Tsakiridis, Theodoros K. Okawara, Gordon S. Kundapur, Vijayananda Bujold, Alexis Ahmed, Naseer Hirmiz, Khalid Kurien, Elizabeth Filion, Edith Gabos, Zsolt Faria, Sergio Louie, Alexander V. Owen, Timothy Wai, Elaine Ramchandar, Kevin Chan, Elisa K. Julian, Jim Cline, Kathryn Whelan, Timothy J.